SUMMARY Affinity (KR) of antibody to human serum transferrin in New Zealand mice was measured by a globulin precipitation technique. KR was low in mice immunized early in life, increased with age of immunization up to [16][17][18][19][20][21][22][23][24][25][26] weeks, and then fell to low levels. KR in young and old NZB mice was increased by immunization with antigen in Freund's complete adjuvant. The correlation between low affinity antibody production and susceptibility to immune complex disease is discussed.
The New Zealand Black (NZB) mouse, New Zealand White (NZW) mouse, and the first generation offspring (NZW/W F1) of the cross between NZB and NZW mice have been extensively studied because of their susceptibility to a disease similar to systemic lupus erythematosus (Helyer and Howie, 1963; Mellors, 1966; Howie and Helyer, 1968; East, 1970) . The demonstration of immunoglobulin and complement components in the renal glomeruli (Aarons, 1964; Mellors, 1965; Lambert and Dixon, 1968) and the presence of circulating antibody to nuclear constituents and to other antigens (Howie and Helyer, 1968; McGiven and Ghose, 1968; Siegel et al., 1972) suggest that the glomerulonephritis of the NZ mice, like that of systemic lupus erythematosus in man, is mediated by immune complexes. Immune complex nephritis can be induced in some strains of mice by neonatal infection with lymphocytic choriomeningitis (LCM) virus. Oldstone and Dixon (1969) have shown that while some strains (B1OD2 new and SWR) are susceptible to such nephritis, others (C3H and A/jax) are resistant. In previous studies (Soothill and Steward, 1971; , we showed that in addition to quantitative differences in antibody produced by these two groups of mice, there are demonstrable qualitative differences; that is, there are differences in the relative affinity (KR) of the antibody produced to protein and hapten antigens. Thus, those strains which are resistant to LCM-induced nephritis made antibody of higher affinity to human serum albumin, human serum transferrin (HST), bovine serum albumin, dinitrophenol-human serum albumin, and nitrophenylacetic acid-rabbit serum albumin than did those strains which were susceptible to the LCM-induced disease.
Because of the possible relevance of antibody affinity to immune complex disease in NZ mice, previous studies were conducted in these mice using HST as the antigen. Three observations were made. First, the relative affinity of anti-HST antibody in NZB and NZB/W F1 mice immunized at 8-12 weeks of age was lower than that seen in any of the 12 other strains tested. Second, the KR rose with age at immunization through the age range tested (up to 26 weeks). This was a unique observation since none of the other strains previously tested showed this age-related variation. Third, immunization with antigen in Freund's complete adjuvant (FCA) in young mice significantly increased both levels and affinity of antibody.
This study is a continuation of earlier studies and examines the relative affinity of antibody produced to HST injected in saline into NZ mice at 26-52 weeks of age, and the ability of old NZ mice to produce high affinity antibody in response to immunization with antigen in FCA.
Methods
Mice were raised by brother-sister mating in a colony originally kept at the Institute of Child Health and subsequently at the Kennedy Institute.
Hybrid (NZB/W F1) mice were raised by reciprocal crosses between NZB and NZW mice. Groups of 8 male and female NZB, NZW, and NZB/W F1 mice were immunized by intraperitoneal injection of 0*5 mg HST (Sigma Chemical) at weekly intervals for 4 weeks and blood was obtained by cardiac puncture 2 weeks after the last injection.
Groups of 7-to 12-week-old NZB males and 48-to 52-week-old NZB males were also immunized intraperitoneally with 0 5 mg HST in FCA (Difco, Detroit; 1: 1 FCA: saline emulsion) at weekly intervals for 4 weeks and bled 2 weeks after the last injection. Determination of antibody affinity (KR) and amount (Abt pmol/10,1l) was performed as previously described using an ammonium sulphate globulin precipitation method (Steward and Petty, 1972a, b) . Negative and positive control sera were included with each assay. Nonspecific binding (seen in the negative control) was subtracted from the test values.
Results

NZB MICE
The mean values for KR and Abt of anti-HST antibody in NZB mice immunized at various ages are shown in Table 1 , and the individual values for KR are shown in Fig. 1 . The rise in KR with increasing age of immunization up to 26 weeks previously reported was confirmed with larger groups of mice. The mean KR was highest in NZB adult males immunized at 16 weeks, but fell thereafter. The KR of antibody from mice immunized at 52 weeks of age (mean KR=1 37 X 105) was not significantly different from that produced by mice immunized at 8-12 weeks of age (mean KR= 2 09 x 105). A similar pattern was seen with NZB females. In NZB females immunized at 26 weeks of age, mean KR=5-5 X 105 I/mol but fell to a low of 1-37 x 1051/mol in those immunized at 52 weeks, In the NZW mice, although the KR was low, the high proportion of nonresponders at young and very old ages made assessment difficult. In NZW males the mean KR was lower than that in NZW females but there was no demonstrable agedependence (Table 2) . The previously reported increase in KR of antibody to HST with increasing age in NZ mice is followed by a decline in mice immunized beyond 16-26 weeks of age. This is accompanied by small changes in Abt. Extensive studies (Mellors, 1966; Howie and Helyer, 1968; Lambert and Dixon, 1968; East, 1970) have shown the age-dependence of many of the autoimmune phenomena, proteinuria, and renal glomerular histopathological changes in NZ mice. Recently a similar age-dependent variation in avidity of antibody to native DNA was shown in these mice (Steward et al., 1975) , with maximum avidity occurring at 20 weeks in both male and female NZB/W F1 mice. As with KR of antibody to HST, the avidity of antibody to DNA falls with age. The striking sex differences in avidity of anti-DNA antibody to NZB/W F1 mice, males being higher than females, was not seen with anti-HST antibody.
Other studies (Elkerbout and Hijmans, 1974a, b) give indirect evidence for production of low affinity antibodies in old NZB mice. In the case of antibodies to DNA, the KR of anti-DNA present in the serum of older animals may be different from the KR of anti-DNA antibody deposited as immune complex in the renal glomeruli. Thus the reported fall in serum anti-DNA KR could reflect selective deposition of high KR anti-DNA antibody in glomeruli. The fall in KR of serum anti-HST could reflect the same phenomenon although HST or other heterologous proteins are not known to participate in the NZ mouse immune complex nephritis. While this explanation cannot at present be refuted, the alternative explanation is that the mean KR of anti-HST antibody synthesized varies with age at immunization.
The mechanisms which determine KR are not known, although it is apparent from the work of Andersson (1972) and others that the affinity of circulating antibody is representative of the affinity of the B-cell surface immunoglobulins. The responsiveness of old NZ mice to immunization with antigen in adjuvant suggests that the low KR antibody elii ited by antigen in saline is not an absolute defect in B-cells. It is important to consider whether agedependent alterations in T-cells or macrophages could result in the observed age-dependent alterations in KR. Reports have noted the decline in T lymphocyte responses with increasing age in NZ mice (Talal, 1970; Rodey et al., 1971; Bach et al., 1973) and the efficacy of thymosin in correcting this abnormality (Dauphinee et al., 1974; Gershwin et al., 1974) . Although deficient T-cell function might explain failure of T-B cell co-operation and resultant low affinity antibody in the old mouse, it could not, on the basis of present data, explain the low KR values seen in the very young mouse.
Less attention has been paid to the function of macrophages in NZ mice. Thomas and Weir (1972) showed that peritoneal exudate cells of old NZB mice take up more bovine serum albumin than do such cells from young mice but that old NZB mice failed to degrade such protein as efficiently as the younger mice. Using the clearance of125_ labelled polyvinylpyrrolidone as a measure of macrophage function, it had been shown that macrophage function in NZB/W F1 mice declines with increasing age (Morgan and Steward, 1976) . Such reticuloendothelial inefficiencies could contribute to less efficient processing of antigen and thus to lower antibody affinity.
If, as we have postulated, antibody of low affinity is important in determining predisposition of an animal to chronic soluble complex disease, it might be expected that production of low affinity antibody would occur either at the time at which immunization with the immunopathogenic antigen takes place, or at the time of onset of immune complex disease. The demonstration within the first week of life of antibody to DNA in NZ mice (Siegel et al., 1972) suggested that transplacental or neonatal infection with virus could be the initial event leading to immune complex disease. The data of Steward et al. (1975) with respect to anti-DNA and the data presented here with respect to HST support the suggestion that both at the time of initial (neonatal) immunization and at the time of occurrence of severe disease (after 6 months of age) the mean KR of serum antibody is low.
It is clear that demonstration of low affinity antibody to HST does not prove the production of or the pathogenic potential of low affinity antibody to viral agents. An assumption must be made that, within limits, NZ mice make low affinity antibody to many, if not all antigens, and that the relatively low affinity of anti-HST antibody accurately reflects the potential of that strain for making antibody of any given affinity. Studies of other strains have shown that 'high affinity strains' (A, C3H) make antibody of high affinity to all antigens tested (HST, DNA, human and bovine serum albumin, dinitrophenolhuman serum albumin, nitrophenylacetic acid), whereas 'low affinity strains' make antibody of low affinity to the same antigens. Therefore, the affinity of the antibody response may be central to the disease process. The demonstrated effect of adjuvant substances on such a response may be of potential therapeutic importance in preventing or treating such disease.
The age-dependent variations in affinity of antibody to HST and to DNA (Steward et al., 1975) are difficult to ascribe to a single mechanism. It is likely that such variations arise as a result of the interaction of the several age-related deficiencies already clearly described for these mice.
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